Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000638301 | SCV000759795 | pathogenic | Glycine encephalopathy | 2022-10-08 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 3-21 of the GLDC gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. A similar copy number variant has been observed in individual(s) with glycine encephalopathy (PMID: 26179960). The region of the GLDC gene that includes exon(s) 3-9 has been determined to be clinically significant (PMID: 17361008, 27362913). Therefore, deletions that encompass that region are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |